Janus Henderson Group plc 13D and 13G filings for Neurocrine Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-09 11:05 am Sale |
2022-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
2,415,638 2.500% |
-5,030,201 (-67.56%) |
Filing |
| 2022-02-10 4:46 pm Sale |
2021-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
7,445,839 7.800% |
-1,998,282 (-21.16%) |
Filing |
| 2021-04-12 2:46 pm Purchase |
2021-03-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
9,444,121 10.000% |
136,201 (+1.46%) |
Filing |
| 2021-02-11 4:55 pm Purchase |
2020-12-31 | 13G | Neurocrine Biosciences, Inc. NBIX |
JANUS HENDERSON GROUP PLC JHG |
9,307,920 9.900% |
1,934,408 (+26.23%) |
Filing |